Prot #KD025-215: A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Project: Research project

Project Details

StatusActive
Effective start/end date1/21/21 → 1/21/24

Funding

  • Kadmon Corporation, LLC (Prot #KD025-215)